Related Experiment Video
Updated: May 22, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Evaluating the compatibility, stability, and antimicrobial effectiveness of vancomycin and cefepime admixtures in
Richard W Dudley1, Susan J Lewis2,3, Mariann D Churchwell4
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Findlay, 1000 North Main Street, Findlay, OH, USA. dudley@findlay.edu.
Abstract:
Peritoneal dialysis (PD) is a home-based option associated with peritonitis, a serious complication preferably treated with intraperitoneal (IP) antibiotics. Vancomycin and cefepime are commonly used empiric treatments, but data on their combined compatibility in PD solutions are limited. This study evaluated the in vitro physical compatibility, chemical stability, and antimicrobial activity of vancomycin (1-2 g) and cefepime (1 g) admixtures in Dianeal 2.5% and Extraneal 7.5% solutions. Admixtures were stored at 4 °C, 25 °C, and 37 °C for 168 h and assessed using visual inspection, optical density, pH, high-performance liquid chromatography, disk diffusion, and minimum inhibitory concentration testing. All admixtures remained physically compatible. At 4 °C, both antibiotics maintained ≥ 90% of their initial concentration over 168 h. At 25 °C, vancomycin remained stable throughout, while cefepime's stability varied from 72 to 168 h in the two solutions. At 37 °C, vancomycin remained stable for 120-168 h, whereas cefepime was stable for 8-24 h. Antimicrobial activity against Staphylococcus aureus and Pseudomonas aeruginosa was preserved for 120 h across all conditions. These findings support the use of vancomycin-cefepime admixtures when refrigerated for up to 7 days, with cefepime remaining stable for 8-24 h at 37 °C, exceeding the minimum recommended intraperitoneal dwell time of 6 h.
Insights
This study found vancomycin and cefepime admixtures are compatible in peritoneal dialysis solutions. Refrigerated storage up to 7 days maintains stability, supporting combined antibiotic use for peritonitis treatment.
Area of Science:
- Nephrology
- Infectious Diseases
- Pharmaceutical Sciences
Background:
- Peritoneal dialysis (PD) is a common home-based treatment for kidney failure.
- Peritonitis is a serious complication of PD, often treated with intraperitoneal (IP) antibiotics.
- Limited data exist on the compatibility of commonly used antibiotics like vancomycin and cefepime in PD solutions.
Purpose of the Study:
- To evaluate the in vitro physical compatibility, chemical stability, and antimicrobial activity of vancomycin and cefepime admixtures in PD solutions.
- To determine optimal storage conditions and duration for combined vancomycin-cefepime therapy in PD.
- To provide evidence supporting the combined use of these antibiotics for peritonitis management in PD patients.
Main Methods:
- Vancomycin and cefepime were admixed in Dianeal 2.5% and Extraneal 7.5% PD solutions.
- Admixtures were stored at 4°C, 25°C, and 37°C for 168 hours.
- Assessed physical compatibility, chemical stability (HPLC, pH), and antimicrobial activity (disk diffusion, MIC) against Staphylococcus aureus and Pseudomonas aeruginosa.
Main Results:
- All admixtures were physically compatible.
- At 4°C, both antibiotics maintained >90% concentration for 168 hours.
- At 25°C, vancomycin was stable throughout; cefepime stability ranged from 72-168 hours.
- At 37°C, vancomycin was stable for 120-168 hours, while cefepime stability was 8-24 hours.
- Antimicrobial activity was preserved for 120 hours across all conditions.
Conclusions:
- Vancomycin and cefepime admixtures are physically compatible in PD solutions.
- Refrigerated storage (4°C) up to 7 days supports the stability of both antibiotics.
- At 37°C, cefepime stability of 8-24 hours exceeds the minimum IP dwell time, supporting its use in combination therapy.
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Dialysis
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis I: Introduction and Procedure
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
